Causal relationship between oral/gut microbiota and lung cancer: a two-sample Mendelian randomization study.
1/5 보강
[PURPOSE] Several studies have already proven a significant correlation between the microbiota and lung cancer.
APA
Huang ZJ, Wu L, et al. (2025). Causal relationship between oral/gut microbiota and lung cancer: a two-sample Mendelian randomization study.. Discover oncology, 16(1), 2027. https://doi.org/10.1007/s12672-025-03853-w
MLA
Huang ZJ, et al.. "Causal relationship between oral/gut microbiota and lung cancer: a two-sample Mendelian randomization study.." Discover oncology, vol. 16, no. 1, 2025, pp. 2027.
PMID
41186872 ↗
Abstract 한글 요약
[PURPOSE] Several studies have already proven a significant correlation between the microbiota and lung cancer. In this study, we explore the potential relative oral and gut microbiota which influence the risk of lung cancer.
[METHODS] We utilized genome-wide association study (GWAS) data from oral microbiota (2984 healthy individuals) and gut microbiota (2002 healthy individuals) and lung cancer with a two-sample Mendelian randomization (MR) analysis method. In this analysis, oral microbiota and gut microbiota were conducted as exposure. Lung cancer data obtained from GWAS including a total of 212,453 individuals. Inverse-variance weighted (IVW) method was used as the primary method.
[RESULTS] IVW analysis identified that genus Pauljensenia, Capnocytophaga and Aggregatibacter in oral microbiota are potentially protective against lung cancer. On the contrary, higher abundances of bacteria within the genus Granulicatella, Streptococcus, Saccharimonadaceae TM7x and Neisseria in oral microbiota were associated with increased lung cancer risk. Among gut bacteria, species Enterococcus faecalis were positively associated with an increased risk of lung cancer.
[CONCLUSION] The findings of this study suggest a potential causal relationship between distinct oral and gut microbial communities and lung cancer risk, offering valuable insights into microbial candidates that may serve as targets for future diagnostic innovations.
[METHODS] We utilized genome-wide association study (GWAS) data from oral microbiota (2984 healthy individuals) and gut microbiota (2002 healthy individuals) and lung cancer with a two-sample Mendelian randomization (MR) analysis method. In this analysis, oral microbiota and gut microbiota were conducted as exposure. Lung cancer data obtained from GWAS including a total of 212,453 individuals. Inverse-variance weighted (IVW) method was used as the primary method.
[RESULTS] IVW analysis identified that genus Pauljensenia, Capnocytophaga and Aggregatibacter in oral microbiota are potentially protective against lung cancer. On the contrary, higher abundances of bacteria within the genus Granulicatella, Streptococcus, Saccharimonadaceae TM7x and Neisseria in oral microbiota were associated with increased lung cancer risk. Among gut bacteria, species Enterococcus faecalis were positively associated with an increased risk of lung cancer.
[CONCLUSION] The findings of this study suggest a potential causal relationship between distinct oral and gut microbial communities and lung cancer risk, offering valuable insights into microbial candidates that may serve as targets for future diagnostic innovations.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans.
- Metastatic Pancreatic Adenocarcinoma with Germline BLM and Somatic ATM Mutations: A Case Report and Review of DNA Damage Response.